Acute Effects of Spirulina on Postprandial Glycemic Responses and Arterial Blood Pressure
- Conditions
- Appetitive BehaviorBlood PressurePotential Abnormality of Glucose Tolerance
- Registration Number
- NCT05484336
- Lead Sponsor
- Agricultural University of Athens
- Brief Summary
This study investigated the effects of three doses of spirulina in glucose beverages on postprandial glycemic responses, arterial blood pressure, and subjective satiety.
- Detailed Description
This study aimed to determine the effects of three different doses (4, 6 and 8 g) of spirulina in glucose beverages on postprandial glycemic responses, blood pressure, and subjective appetite responses in healthy young adults.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 13
- healthy
- non-smokers
- men and women
- body mass index between 18 and 24.9 kg/m2
- normal blood pressure (systolic blood pressure <120 mmHg and diastolic blood pressure <80 mmHg)
- normal fasting blood glucose concentrations (<100 mg/dL)
- Medical conditions (e.g., cardiovascular diseases, diabetes mellitus, kidney or liver conditions, severe clinical depression, gastrointestinal disorders)
- Under medications known to affect glycemia (glucocorticoids, metformin, thiazide diuretics)
- Allergy to spirulina
- Pregnancy
- Lactation
- Competitive sports
- Alcohol abuse
- Drug dependency
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Capillary blood glucose responses 2 hours Clinically useful change in blood glucose, defined as the restoration of glucose within normal limits during 2hr glucose tolerance test
Blood pressure 2 hours Useful change in systolic and diastolic blood pressure before and 2hr after consumption of the three doses of spirulina in beverages
- Secondary Outcome Measures
Name Time Method Subjective appetite ratings 2 hours Useful change in subjective appetite using visual analogue scales with a score 0 to 10 (given in form of booklet, one scale per page) at baseline, 15, 30, 45, 60, 90 and 120. The minimum or maximum score will be evaluated if it is better or worse depending on the appetite variable e.g. hunger, satiety, desire to eat etc.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Agricultural University of Athens
🇬🇷Athens, Attica, Greece
Agricultural University of Athens🇬🇷Athens, Attica, Greece